Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06523387 · ClinicalTrials.gov registry record · NA

Online Pivotal Response Treatment Training in Autism Spectrum Disorder

A NA study of Autism Spectrum Disorder and Autism, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT06523387 is a NA study of Autism Spectrum Disorder and Autism that is actively recruiting participants, run by Stanford University. The registered enrollment target is 44 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06523387, a NA study of Autism Spectrum Disorder and Autism, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

This is a research study that will assess the effects of a Pivotal Response Treatment Online Training Course (PRT-O) for training parents of children with Autism Spectrum Disorder (ASD). The study will specifically investigate whether participants can learn to deliver PRT effectively following participation in the Online training.

Interventions

  • BEHAVIORAL Pivotal Response Treatment Online (PRT-O) Course

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2026-01-30
Est. Completion 2028-12-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT06523387

The ClinicalTrials.gov registry entry for NCT06523387 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (67% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Pivotal Response Treatment Online (PRT-O) Course is the first listed.

NCT06523387 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06523387 about?

NCT06523387 is a clinical study titled "Online Pivotal Response Treatment Training in Autism Spectrum Disorder". This is a research study that will assess the effects of a Pivotal Response Treatment Online Training Course (PRT-O) for training parents of children with Autism Spectrum Disorder (ASD). The study will specifically investigate whether participants can learn to deliver PRT effectively following parti...

What is the current status of trial NCT06523387?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2026-01-30. Estimated completion is 2028-12-30.

What conditions does trial NCT06523387 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism.

What interventions are being tested in trial NCT06523387?

The interventions under investigation include: Pivotal Response Treatment Online (PRT-O) Course (BEHAVIORAL).

Who is sponsoring clinical trial NCT06523387?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06523387 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.